CSI Market
Sign In | Register

Halozyme Therapeutics Inc (HALO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access HALO Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Halozyme Therapeutics Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent163.14
Available-for-sale Securities, Debt Securities, Current MA67.94
Cash & Short-term Investments230.00
Accounts receivable453.33
Inventories137.14
Derivatives, Collateral, Regulatory, Deferred0.80
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.00
Total Current Assets933.02
Equipment/Property/Plant Net83.70
Goodwill net581.73
Intangible Assets922.44
Long-term investments0.85
Financial Instruments1.30
Deferred, Prepaid and Other Assets, Noncurrent164.15
Other Assets, Noncurrent0.89
Debt Securities Available For Sale Excluding Accrued Interest Current8.87
Accounts Receivable And Contract With Customer Asset After Allowance For Credit Loss Current457.99
Prepaid Expense And Other Assets Noncurrent50.92
Total Assets2,577.41
Liabilities
Accounts Payable, Current AC23.61
Accrued Liabilities, Current AC111.86
Financial Instruments5.10
Long-term Debt, Current Maturities LO208.97
Other Liabilities, Current0.00
Taxes Payable26.43
Total Current Liabilities344.44
Long-term debt1,937.68
Total Long-term Debt1,937.68
Financial Instruments, Insurance, Noncurrent7.20
Other liabilities, Noncurrent144.54
Total Liabilities2,433.87
Stockholders' Equity
Common Stock Value0.11
Additional Paid In Capital Common Stock0.00
Retained Earnings / Accumulated Deficit151.26
Accumulated Other Comprehensive Income-7.83
Other Equity-7.83
Common Stockholder's Equity143.54
Total Stockholder's Equity143.54
Liabilities & Stockholder's Equity2,577.41
4 historic quarters locked

Sign in to unlock the full Halozyme Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Halozyme Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001159036-26-000104

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.